anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Equillium · conference-presentation

Equillium | Results Presentation Deck | 32 slides

32 pages · 5 arc beats · 2 loops

Conference-Presentation Download JSON
Unlock

Equillium | Results Presentation Deck | 32 slides

Equillium · 2022-09
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON
Narrative range 27 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 1 slides 100% 1/1 slides 100% 1/1 slides · 6 hits
— 0/1 slides
100% 1/1 slides
— 0/1 slides
100% 1/1 slides · 2 hits 100% 1/1 slides Agitate 2 slides 100% 2/2 slides 100% 2/2 slides · 8 hits
— 0/2 slides
50% 1/2 slides
— 0/2 slides
100% 2/2 slides · 4 hits 100% 2/2 slides · 3 hits Solution 22 slides 100% 22/22 slides 100% 22/22 slides · 97 hits
— 0/22 slides
45.5% 10/22 slides · 11 hits 13.6% 3/22 slides 100% 22/22 slides · 23 hits 100% 22/22 slides · 43 hits Key Takeaways 1 slides 100% 1/1 slides 100% 1/1 slides · 6 hits
— 0/1 slides
100% 1/1 slides
— 0/1 slides
100% 1/1 slides
— 0/1 slides
KPI Overview 1 slides 100% 1/1 slides 100% 1/1 slides · 14 hits
— 0/1 slides
100% 1/1 slides · 2 hits
— 0/1 slides
100% 1/1 slides
— 0/1 slides

Slide inventory

32
every slide · same image gating as the playbook
01
Slide 1
Exhibit 99.1 indicates this is likely a regulatory or investor relations filing.front_matter
Open slide detail
02
other
Open slide detail
03
other
Open slide detail
04
transition
Open slide detail
05
The slide uses a list-based layout to present key metrics with corresponding descriptions.size_opportunity
Open slide detailBeat · KPI Overview
06
The slide includes the KDIGO 2012 CKD prognosis matrix.present_framework
Open slide detail
07
The slide uses a process-oriented diagram to visualize clinical milestones.present_framework
Open slide detail
08
Data sourced from the Accelerating Medicines Partnership (AMP) Lupus Network.analyze_data
Open slide detailBeat · Key Takeaways
09
The slide uses stacked bar charts to compare response rates (Complete, Partial, No Response) at different time intervals for two drugs.diagnose_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
10
front_matter
Open slide detailBeat · AgitateLoop · Cost Of Inaction
11
Includes scientific citation at the bottom.establish_context
Open slide detailBeat · SolutionLoop · Cost Of Inaction
12
The slide uses a 'Bench to Bedside' narrative structure to present scientific evidence.illustrate_case
Open slide detailBeat · SolutionLoop · Cost Of Inaction
13
The slide uses a visual process flow to explain the mechanism of action.present_solution
Open slide detailBeat · SolutionLoop · Cost Of Inaction
14
transition
Open slide detailBeat · SolutionLoop · Cost Of Inaction
15
The slide outlines a clinical trial structure with 5 cohorts ranging from 0.4 to 3.2 mg/kg.present_framework
Open slide detailBeat · SolutionLoop · Cost Of Inaction
16
Includes clinical trial abbreviations and source citation in footer.summarize
Open slide detailBeat · SolutionLoop · Cost Of Inaction
17
The slide appears to be a template or placeholder with only the title present.present_framework
Open slide detailBeat · SolutionLoop · Cost Of Inaction
18
The slide compares clinical trial data for two different drugs using different metrics (fold change vs median % reduction).analyze_data
Open slide detailBeat · SolutionLoop · Cost Of Inaction
19
summarize
Open slide detailBeat · SolutionLoop · Cost Of Inaction
20
transition
Open slide detailBeat · SolutionLoop · Cost Of Inaction
21
The slide outlines a clinical trial protocol for Itolizumab in patients with active proliferative lupus nephritis (apLN).present_framework
Open slide detailBeat · SolutionLoop · Cost Of Inaction
22
Data includes age, gender, race, country, disease duration, treatment history, LN class, and renal function metrics.analyze_data
Open slide detailBeat · SolutionLoop · Cost Of Inaction
23
Data cut-off date: September 2, 2022.summarize
Open slide detailBeat · SolutionLoop · Cost Of Inaction
24
The slide uses a structured table-like layout to categorize safety findings.summarize
Open slide detailBeat · SolutionLoop · Cost Of Inaction
25
The chart shows concentration over time for different dosage groups (0.4 to 3.2 mg/kg) for Type A and Type B subjects.analyze_data
Open slide detailBeat · SolutionLoop · Cost Of Inaction
26
The chart uses stacked bars to visualize the breakdown of Complete Response (two categories), Partial Response, and No Response.analyze_data
Open slide detailBeat · SolutionLoop · Cost Of Inaction
27
The chart tracks subject progress over time (weeks) with markers for treatment milestones and clinical responses.analyze_data
Open slide detailBeat · SolutionLoop · Cost Of Inaction
28
The chart uses a waterfall-style visualization to show individual subject outcomes relative to a 50% reduction threshold.analyze_data
Open slide detailBeat · SolutionLoop · Cost Of Inaction
29
The chart includes error bars representing standard error (SE) and sample sizes (n) at each time point.analyze_data
Open slide detailBeat · SolutionLoop · Cost Of Inaction
30
The table compares interim analysis data for Itolizumab against historical AMP SoC data across 3, 6, and 12-month intervals.compare_peers
Open slide detailBeat · SolutionLoop · Cost Of Inaction
31
Slide 31 of a presentation deck.summarize
Open slide detailBeat · SolutionLoop · Cost Of Inaction
32
state_next_steps
Open slide detail